Last reviewed · How we verify

NCT03850197

Tubomanometry and EarPopper Devices for Eustachian Tube Function Testing

Completed Last updated 13 November 2020
What this trial tests

trial testing EarPopper in Eustachian Tube Dysfunction in 30 participants. Completed in 18 November 2019.

Timeline
27 February 2019
Primary endpoint
18 November 2019
18 November 2019

Quick facts

Lead sponsorCuneyt M. Alper
StatusCompleted
Study typeOBSERVATIONAL
Enrollment30
Start date27 February 2019
Primary completion18 November 2019
Estimated completion18 November 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Cuneyt M. Alper — full company profile →

Who can join

Adults 5 to 60, any sex, with Eustachian Tube Dysfunction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Eustachian tube (ET) is a biological tube that links the middle ear to the back of the nose and throat. It has several functions, of which the most important is to maintain optimal middle-ear health. Eustachian tube dysfunction (ETD) can result in pain or a popping sensation in the ears when flying in an airplane or going up a tall building in an elevator. Many people with ETD also suffer from ear problems such as repeated middle-ear infections or fluid in the ears. However, there are very few easily-administered tests to measure and assess Eustachian tube function (ETF). Tubomanometry is one of these tests, however it is expensive and used to measure ETF only in research settings. In this study, the investigators propose that using a combination of two readily available devices, the EarPopper and a tympanometer, will work in a manner similar to a Tubomanometer to test ET function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of EarPopper

Trials testing the same drug.

Other recruiting trials for Eustachian Tube Dysfunction

Currently open trials in the same condition.

Other Cuneyt M. Alper trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03850197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing